2020•United States. Government Accountability OfficeRequires access

National Biodefense Strategy: Opportunities and Challenges with Early Implementation, Statement of Christopher P Currie, Director, Homeland Security and Justice Statement of Mary Denigan-Macauley, Director, Health Care, Testimony Before the Committee on Oversight and Reform, House of Representatives

Chris Currie, Mary Denigan-Macauley

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Biodefense, Statement (logic), Homeland security, Political science, Economic Justice, Public administration, Law, Medicine

Back to paper search Browse research topics Original source

National Biodefense Strategy: Opportunities and Challenges with Early Implementation, Statement of Christopher P Currie, Director, Homeland Security and Justice Statement of Mary Denigan-Macauley, Director, Health Care, Testimony Before the Committee on Oversight and Reform, House of Representatives — Research Paper | ScholarLens